Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 6, 2007, Pages 2831-2836

  Mizuno, Shimon ^a   Nishiwaki, Akiko ^a   Morita, Hiroshi ^a   Miyake, Takatomo ^a   Ogura, Yuichiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PADGEM PROTEIN; SODIUM CHLORIDE; TRIAMCINOLONE ACETONIDE; FLUORESCENT DYE; GLUCOCORTICOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM; FLUOROGRAPHY; HISTOLOGY; LEUKOCYTE; LEUKOCYTE ROLLING; MALE; MICROCIRCULATION; MOLECULAR DYNAMICS; NERVE LIGATION; NERVE SHEATH; NONHUMAN; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA ISCHEMIA; RETINA VEIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; ANIMAL; CELL COMMUNICATION; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENETICS; INJECTION; ISCHEMIA; LONG EVANS RAT; METABOLISM; RETINA BLOOD VESSEL; RETINA DISEASE; RETINA MACULA CYSTOID EDEMA;

ACRIDINE ORANGE; ANIMALS; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; GENE EXPRESSION; GLUCOCORTICOIDS; INJECTIONS; INTERCELLULAR ADHESION MOLECULE-1; ISCHEMIA; LEUKOCYTES; MACULAR EDEMA, CYSTOID; MALE; P-SELECTIN; RATS; RATS, LONG-EVANS; RETINAL DISEASES; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIAMCINOLONE ACETONIDE;

EID: 34347217097     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1041     Document Type: Article

References (40)

1. Tano Y, Sugita G, Abrams G, Machemer R. Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol. 1980;89:131-136.
2. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 1980;90:810-816.
3. Wilson CA, Berkowitz BA, Sato Y, Ando N, Harada JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol. 1992;110:1155-1159.
4. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 2002;86:247-248.
5. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:782-783.
6. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927.
7. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003;121:57-61.
8. Ohguro N, Okada AA, Tano Y. Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2004;242:444-445.
9. Jennings T, Rusin MM, Tessler HH, Cunha-Vaz JG. Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1988;32:385-391.
10. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001;108:765-772.
11. Okada AA, Wakabayashi T, Morimura Y, et al. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol. 2003;87:968-971.
12. Danis RP, Ciulla TA, Pratt LM, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 2000;20:244-250.
13. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol. 2003;87:462-468.
14. Zamir E, Read RW, Smith RE, Wang RC, Rao NA. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology. 109:798-805, 2002; discussion 805-797.
15. Stern AL, Taylor DM, Dalburg LA, Cosentino RT. Pseudophakic cystoid maculopathy: a study of 50 cases. Ophthalmology. 1981;88:942-946.
16. Tsujikawa A, Ogura Y, Hiroshiba N, Miyamoto K, Kiryu J, Honda Y. In vivo evaluation of leukocyte dynamics in retinal ischemia reperfusion injury. Invest Ophthalmol Vis Sci. 1998;39:793-800.
17. Tsujikawa A, Ogura Y, Hiroshiba N, et al. Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. Invest Ophthalmol Vis Sci. 1999;40:1183-1190.
18. Matsubara A, Tomida K, Matsuda Y, et al. Protective effects of selectin ligands/inhibitor (SKK-60060) against retinal ischemia-reperfusion injury. Exp Eye Res. 2000;71:283-293.
19. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3-6.
20. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859-873.
21. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991;67:1033-1036.
22. Stefansson E, Wilson CA, Schoen T, Kuwabara T. Experimental ischemia induces cell mitosis in the adult rat retina. Invest Ophthalmol Vis Sci. 1988;29:1050-1055.
23. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Honda Y. Quantitative evaluation of leukocyte dynamics in retinal microcirculation. Invest Ophthalmol Vis Sci. 1995;36:123-130.
24. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Miyamoto K, Honda Y. Visualization and quantitative analysis of leukocyte dynamics in retinal microcirculation of rats. Invest Ophthalmol Vis Sci. 1996;37:1341-1347.
25. Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res. 1991;53:573-582.
26. Nishiwaki A, Ueda T, Ugawa S, Shimada S, Ogura Y. Upregulation of P-selectin and intercellular adhesion molecule-1 after retinal ischemia reperfusion injury. Invest Ophthalmol Vis Sci. 2003;44:4931-4935.
27. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
28. Dustin ML, Rothlin R, Bhan AL, Dinarello CA, Splinger TA. Induction by IL 1 and interferon-gamma. J Immunol. 1993;151:6338-6346.
29. Penfold PL, Wen L, Madigan MC, King NJ, Provis JM. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci. 2002;43:3125-3130.
30. Penfold PL, Wen L, Madigan MC, Gillies MC, King NJ, Provis JM. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol. 2000;121:458-465.
31. Lu M, Perez VL, Ma N, et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999;40:1808-1812.
32. Miyamoto K, Khosrof S, Bursell SE, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol. 2000;156:1733-1739.
33. Campochiaro PA, Hackett SF. Ocular neovascularization: a valuable model system. Oncogene. 2003;22:6537-6548.
34. Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res. 2005;80:249-258.
35. Sears JE, Hoppe G. Triamcinolone acetonide destabilizes VEGF mRNA in Müller cells under continuous cobalt stimulation. Invest Ophthalmol Vis Sci. 2005;46:4336-4341.
36. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46:1440-1444.
37. Funatsu H, Yamashita H, Sakata K, et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic edema. Ophthalmology. 2005;112:806-816.
38. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J. 2006;20:323-325.
39. Tombran-Tink J, Lara N, Apricio SE, et al. Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells. Exp Eye Res. 2004;78:945-955.
40. Fukuchi T, Takahashi K, Sho K, Matsumura M. Optical coherence tomography (OCT) findings in normal retia and laser-induced choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol. 2001;239:41-46.